Jubilant Pharmo

{
  "main_header": {
    "sid": 525933,
    "name": "Jubilant Pharmo",
    "stock_name": "Jubilant Pharmo",
    "full_name": "Jubilant Pharmova Ltd",
    "name_url": "stocks-analysis/jubilant-pharmo",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,008.60",
    "chg": 27.35,
    "chgp": "2.79%",
    "dir": 1,
    "prev_price": "981.25",
    "mcapval": "15,999.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530019,
    "symbol": "JUBLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE700A01033",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "1.53 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jubilant-pharmo-525933-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jubilant Pharmova Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-sell-3975704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JubilantPharmov_mojoScore_3975704.png",
        "date": "2026-05-05 10:10:53",
        "description": "Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-sell-3960577",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JubilantPharmov_mojoScore_3960577.png",
        "date": "2026-04-24 10:10:43",
        "description": "Jubilant Pharmova Ltd is rated Sell by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Jubilant Pharmova Gains 2.23%: Technical Shift and Financial Challenges Shape Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-gains-223-technical-shift-and-financial-challenges-shape-week-3952618",
        "imagepath": "",
        "date": "2026-04-18 17:03:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> Upgrade to Sell rating on technical improvements despite financial pressures</p>\n                    <p><strong>13 Apr:</strong> Technical momentum shifts from strongly bearish to mildly bearish</p>\n                    <p><strong>17 Apr:</strong> Stock closes at Rs.911.60, up 0.72% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.891.75</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.911.60</div><div class=\"stat-change positive\">+2.23%</div></div>\n       ..."
      },
      {
        "title": "Jubilant Pharmova Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3944133",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JubilantPharmov_mojoScore_3944133.png",
        "date": "2026-04-13 08:05:49",
        "description": "Jubilant Pharmova Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 10 April 2026, reflecting nuanced shifts across technical indicators and valuation metrics despite ongoing financial challenges. This recalibration follows a detailed analysis of the company’s quality, valuation, financial trends, and technical outlook, providing investors with a clearer perspective on its current market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-technical-momentum-shifts-amid-mixed-market-signals-3943945",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JubilantPharmov_technicaldot_3943945.png",
        "date": "2026-04-13 08:02:02",
        "description": "Jubilant Pharmova Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 1.26%, the stock’s broader trend signals caution amid mixed signals from MACD, RSI, and moving averages, underscoring the challenges facing this small-cap pharmaceutical player in a volatile market environment."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-strong-sell-3937253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JubilantPharmov_mojoScore_3937253.png",
        "date": "2026-04-08 10:10:53",
        "description": "Jubilant Pharmova Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-strong-sell-3921382",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JubilantPharmov_mojoScore_3921382.png",
        "date": "2026-03-28 10:10:27",
        "description": "Jubilant Pharmova Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Jubilant Pharmova Ltd Surges 7.07% to Day's High of Rs 874.55 — Outperforms Sector by 6.15 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-hits-intraday-high-with-707-surge-on-24-mar-2026-3910555",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JubilantPharmov_priceRelatedfactors_3910555.png",
        "date": "2026-03-24 13:00:50",
        "description": "The Sensex gained 2.05% on 24 Mar 2026, yet Jubilant Pharmova Ltd outpaced the broader market with a 7.07% surge, reaching an intraday high of Rs 874.55. This 6.15 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market lift."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-strong-sell-3896238",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JubilantPharmov_mojoScore_3896238.png",
        "date": "2026-03-17 10:10:32",
        "description": "Jubilant Pharmova Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 March 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 395,
    "sid": "525933",
    "stock_news_url": "https://www.marketsmojo.com/news/jubilant-pharmova-525933"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-Apr-2026",
      "details": "Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "24-Apr-2026",
      "details": "Investor Meet",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Meeting Held On May 22 2026",
      "datetime": "24-Apr-2026",
      "details": "Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2026. and Recommendation of Final Dividend if any for the Financial Year ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "22 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has declared <strong>500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has announced <strong>1:5</strong> stock split, ex-date: 17 Mar 06",
          "dt": "2006-03-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jubilant Pharmova Ltd is Rated Sell

2026-05-05 10:10:53

Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook.

Read full news article

Jubilant Pharmova Ltd is Rated Sell

2026-04-24 10:10:43

Jubilant Pharmova Ltd is rated Sell by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Jubilant Pharmova Gains 2.23%: Technical Shift and Financial Challenges Shape Week

2026-04-18 17:03:07

Key Events This Week

13 Apr: Upgrade to Sell rating on technical improvements despite financial pressures

13 Apr: Technical momentum shifts from strongly bearish to mildly bearish

17 Apr: Stock closes at Rs.911.60, up 0.72% on the day

Week Open

Rs.891.75

Week Close

Rs.911.60

+2.23%

...

Read full news article

Jubilant Pharmova Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-04-13 08:05:49

Jubilant Pharmova Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 10 April 2026, reflecting nuanced shifts across technical indicators and valuation metrics despite ongoing financial challenges. This recalibration follows a detailed analysis of the company’s quality, valuation, financial trends, and technical outlook, providing investors with a clearer perspective on its current market positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-13 08:02:02

Jubilant Pharmova Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 1.26%, the stock’s broader trend signals caution amid mixed signals from MACD, RSI, and moving averages, underscoring the challenges facing this small-cap pharmaceutical player in a volatile market environment.

Read full news article

Jubilant Pharmova Ltd is Rated Strong Sell

2026-04-08 10:10:53

Jubilant Pharmova Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Jubilant Pharmova Ltd is Rated Strong Sell

2026-03-28 10:10:27

Jubilant Pharmova Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.

Read full news article

Jubilant Pharmova Ltd Surges 7.07% to Day's High of Rs 874.55 — Outperforms Sector by 6.15 Percentage Points

2026-03-24 13:00:50

The Sensex gained 2.05% on 24 Mar 2026, yet Jubilant Pharmova Ltd outpaced the broader market with a 7.07% surge, reaching an intraday high of Rs 874.55. This 6.15 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market lift.

Read full news article

Jubilant Pharmova Ltd is Rated Strong Sell

2026-03-17 10:10:32

Jubilant Pharmova Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 March 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News